GlaxoSmithKline looks set to have another year without US generic competition to its respiratory blockbuster Advair, after the FDA raised problems with a challenger. Reuters reports today that ...
GlaxoSmithKline has confirmed it will face a challenging 2019 as generics of its big-selling Advair drug finally reach the US, as it continues the transformation of its business. The FDA approved the ...
Advair is used to treat asthma and chronic obstructive pulmonary disease. The Association for Accessible Medicines is voicing strong opposition that the proposed U.S.-Mexico-Canada trade agreement ...
These useful navigation apps help you avoid bumper-to-bumper traffic and get to your destination quickly, but which is best? I tested both map services and found a clear winner. My PCMag career began ...
Inhaled steroids aren’t the go-to treatment for COPD, so your doctor will likely prescribe a bronchodilator, too. This is medicine in an inhaler that relaxes your airway muscles to help you breathe ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...
Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results